2011 | 2 | 276-279
Article title

Prozapalna chemokina CCL2/MCP-1 oraz białko C-reaktywne u młodych pacjentów z retinopatią cukrzycową

Title variants
Languages of publication
  • Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000; 18: 217–242.
  • Romagnani P, Lasagni L, Annunziato F, et al. CXC chemokines: the regulatory link between inflammation and angiogenesis.Trends Immunol 2004; 25: 201–209.
  • Z orena K, Myśliwska J, Myśliwiec M, et al. Modulatory factors responsible for neoangiogenesis in young patients with long-standing diabetes mellitus type 1. Recent Patents Endocr Metabol Immun Drug Disc 2009; 3: 144–149.
  • American Diabetes Association: Diagnosis and Classification of Diabetes. Diabet Care 2010; 33: 62–69.
  • Early Treatment Diabetic Retinopathy Study Research Group. Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report number 11. Ophthalmology 1991; 98(Suppl.): 807–822.
  • The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescent.Pediatrics 2004; 114(Suppl. 24th Report): 555–576.
  • Abu El-Asrar AM, Struyf S, Kangave D, et al. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.Eur Cytokine Netw 2006; 17: 155–165.
  • H ebecker M, Okemefuna AI, Perkins SJ, et al. Molecular basis of C-reactive protein binding and modulation of complement activation by factor H-related protein 4. Mol Immunol 2010; 47: 1347–1355.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.